Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Edna A. Anjos-Valotta"'
Autor:
Diego S. Coutinho, Edna A. Anjos-Valotta, Caio V. M. F. do Nascimento, Ana Lucia A. Pires, Marcelo H. Napimoga, Vinícius F. Carvalho, Rafael C. Torres, Patrícia M. R. e Silva, Marco A. Martins
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
15-deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2) has been described as an anti-inflammatory lipid mediator in several in vitro and in vivo studies, but its effect on allergic pulmonary inflammation remains elusive. The aim of this study was to investiga
Externí odkaz:
https://doaj.org/article/114a231806b0414ea7af2f8b0a1f9de7
Autor:
Amanda C. Cotias, Katharinne Ingrid Moraes de Carvalho, Gina C. Couto, Camila R. Pão, Patrícia M.R. e Silva, Edna A. Anjos-Valotta, Josiane S. Neves, Robson Xavier Faria, Priscilla C. Olsen, Renato S.B. Cordeiro, Magda F. Serra, Marco A. Martins, Jorge Carlos Santos da Costa
Publikováno v:
Anesthesiology. 124:109-120
Background Inhaled lidocaine antagonized bronchospasm in animal models and patients, but adverse effects limited its efficacy. This study evaluated the antibronchospasm potential of the analog JM25-1, exploring in vitro mechanisms and translation to
Autor:
Edna A. Anjos-Valotta, Diego de Sá Coutinho, Patrícia M.R. e Silva, Vinicius F. Carvalho, Caio Victor M. F. do Nascimento, Ana Lucia A. Pires, Rafael Carvalho Torres, Marco A. Martins, Marcelo H. Napimoga
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 8 (2017)
Frontiers in Immunology, Vol 8 (2017)
15-deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2) has been described as an anti-inflammatory lipid mediator in several in vitro and in vivo studies, but its effect on allergic pulmonary inflammation remains elusive. The aim of this study was to investiga
Autor:
Julio Beltrame Daleprane, Patrícia M.R. e Silva, Edna A. Anjos-Valotta, Gina C. Couto, Vinicius F. Carvalho, Renato S.B. Cordeiro, Camila R. R. Pão, Amanda C. Cotias, Magda F. Serra, Patricia Barbosa Jurgilas, Marco A. Martins
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 201(3)
The importance of developing new animal models to assess the pathogenesis of glucocorticoid (GC)-insensitive asthma has been stressed. Because of the asthma-prone background of A/J mice, we hypothesized that asthma changes in these animals would be o
Autor:
Magda F, Serra, Josiane S, Neves, Gina C, Couto, Amanda C, Cotias, Camila R, Pão, Priscilla C, Olsen, Katharinne I Moraes, de Carvalho, Edna A, Anjos-Valotta, Robson X, Faria, Jorge C S, Costa, Renato S B, Cordeiro, Patricia M R, Silva, Marco A, Martins
Publikováno v:
Anesthesiology. 124(1)
Inhaled lidocaine antagonized bronchospasm in animal models and patients, but adverse effects limited its efficacy. This study evaluated the antibronchospasm potential of the analog JM25-1, exploring in vitro mechanisms and translation to an animal m
Autor:
Amanda C. Cotias, Patricia Barbosa Jurgilas, Gina C. Couto, Camila R. Pão, Edna A. Anjos-Valotta, Marco A. Martins, Tatiana P. T. Ferreira, Ana Carolina S. Arantes, Priscilla C. Olsen, Renato S.B. Cordeiro, Magda F. Serra, Ana Lucia A. Pires, Patrícia M.R. e Silva
Publikováno v:
Anesthesiology. 117(3)
Background Evidence suggests that nebulized lidocaine is beneficial in asthma therapy, but to what extent and the mechanisms underlying this effect remain poorly understood. The aim of this study was to assess the impact of lidocaine treatment using